America October 7, 2024
Supreme Court Denies Shkreli’s $64M Disgorgement Rehearing
The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli’s challenge to a $64 million disgorgement…
America October 7, 2024
The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli’s challenge to a $64 million disgorgement…
By Rihem Akkouche
America January 23, 2024
In a pivotal decision, the Second Circuit reaffirmed on Tuesday the lifetime ban on former pharmaceutical tycoon and convicted securities…
By Rihem Akkouche
Business December 8, 2021
Vyera Pharmaceuticals and its parent company Phoenixus AG (formerly Turing Pharmaceuticals) agreed to a $40 million settlement for illegally monopolizing…
By Marivic Cabural Summers
Business January 27, 2020
The Federal Trade Commission (FTC) and New York Attorney General Letitia James filed a lawsuit against ‘Pharma Bro’ Martin Shkreli…
By Marivic Cabural Summers